• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Thromboembolism (2654); Insufficient Information (4580)
Event Date 02/28/2022
Event Type  malfunction  
Event Description
There was an allegation of questionable results from coaguchek xs meter serial number (b)(4) compared to a laboratory using an unknown reagent.The following comparison was provided.On "28/2/2" the meter result was allegedly 1.3 inr.This result was present in the meter memory on (b)(6) 2002.The laboratory result was reportedly 3.5 inr.As the date and time on the meter were set incorrectly, the actual date and time of these results was unknown.On (b)(6) 2022, at an unknown time, it was alleged that the meter result was 1.8 inr.At an unknown time, the laboratory result using an unknown reagent was reportedly 3.8 inr.On (b)(6) 2022 at 5:00 am, it was alleged that the meter result was 6.6 inr.At 7:30 am, the laboratory result using an unknown reagent was reportedly 3.3 inr.The therapeutic range was 3.0-3.5 inr and the patient tests weekly.
 
Manufacturer Narrative
The returned vial of strip lot 54146321 was empty.The meter was provided for investigation where it were tested using retention strips and retention controls.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.1 inr.Qc 2: 5.2 inr.Qc 3: 5.2 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The results alleged by the reporter were not observed in the meter¿s patient result memory.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and the results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." occupation was patient/consumer (patient's caregiver).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14322420
MDR Text Key299161595
Report Number1823260-2022-01306
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 05/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/31/2022
Device Catalogue Number04625374160
Device Lot Number54146321
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/21/2022
Date Manufacturer Received04/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPIRIN; CITALOPRAM; DOCUSATE; EMPAGLIFLOZIN; METOPROLOL; NORTRIPTYLINE; SACUBITRIL; SPIRONOLACTONE; WARFARIN
Patient Age48 YR
Patient SexMale
Patient Weight93 KG
-
-